Global Semaglutide Market Size & Outlook, 2024-2035
Global semaglutide market, 2018-2035 (US$M)
Related Markets
Global semaglutide market highlights
- The global semaglutide market generated a revenue of USD 28,429.9 million in 2024 and is expected to reach USD 93,598.8 million by 2035.
- The market is expected to grow at a CAGR (2025 - 2035) of 10.5% by 2035.
- In terms of segment, ozempic (semaglutide) accounted for a revenue of USD 19,454.8 million in 2024.
- Rybelsus (oral semaglutide) is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Japan is expected to register the highest CAGR from 2025 to 2035.
Global data book summary
| Market revenue in 2024 | USD 28,429.9 million |
| Market revenue in 2035 | USD 93,598.8 million |
| Growth rate | 10.5% (CAGR from 2025 to 2035) |
| Largest segment | Ozempic (semaglutide) |
| Fastest growing segment | Rybelsus (oral semaglutide) |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2035 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Ozempic (semaglutide), Wegovy (semaglutide), Rybelsus (oral semaglutide) |
Other key industry trends
- In terms of revenue, the North America accounted for 74.3% of the global semaglutide market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2035.
- By country, Japan is the fastest growing regional market and is projected to reach USD 1,890.7 million by 2035.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Semaglutide Market Scope
Semaglutide Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global semaglutide market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to semaglutide market will help companies and investors design strategic landscapes.
Ozempic (semaglutide) was the largest segment with a revenue share of 68.43% in 2024. Horizon Databook has segmented the Global semaglutide market based on ozempic (semaglutide), wegovy (semaglutide), rybelsus (oral semaglutide) covering the revenue growth of each sub-segment from 2018 to 2035.
- Global Semaglutide Product Outlook (Revenue, USD Million, 2018-2035)
- Ozempic (semaglutide)
- Wegovy (semaglutide)
- Rybelsus (oral semaglutide)
- Others
- Global Semaglutide Application Outlook (Revenue, USD Million, 2018-2035)
- Type 2 Diabetes Mellitus
- Obesity
- Global Semaglutide Route of Administration Outlook (Revenue, USD Million, 2018-2035)
- Parenteral
- Oral
- Global Semaglutide Distribution Channel Outlook (Revenue, USD Million, 2018-2035)
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Reasons to subscribe to Global semaglutide market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global semaglutide market databook
-
Our clientele includes a mix of semaglutide market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global semaglutide market , including forecasts for subscribers. This global databook contains high-level insights into Global semaglutide market from 2018 to 2035, including revenue numbers, major trends, and company profiles.
Partial client list
Global semaglutide market size, by regions, 2018-2035 (US$M)
Top 10 countries: Semaglutide market size, 2024 (US$M)
Global semaglutide market share, by product, 2024 & 2035 (%, US$M)
Semaglutide market: Opportunity assessment by country
Global semaglutide market, by region, 2024 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
